COAG (Hemab Therapeutics Holdings, Inc. Common Stock) Stock Analysis - Analyst Ratings

Hemab Therapeutics Holdings, Inc. Common Stock (COAG) is a publicly traded the market company. As of May 21, 2026, COAG trades at $26.47 with a market cap of $1.27B and a P/E ratio of 0.00. COAG moved +2.40% today. Year to date, COAG is +0.00%; over the trailing twelve months it is flat. Its 52-week range spans $23.00 to $36.61. Rallies surfaces COAG's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

What do analysts rate COAG?

The average price target is $0.00.

COAG Key Metrics

Key financial metrics for COAG
MetricValue
Price$26.47
Market Cap$1.27B
P/E Ratio0.00
EPS$0.00
Dividend Yield0.00%
52-Week High$36.61
52-Week Low$23.00
Volume206
Avg Volume0
Revenue (TTM)$0
Net Income$0
Gross Margin0.00%

COAG Analyst Consensus

COAG analyst coverage data. Average price target: $0.00.

Latest COAG News

Recent COAG Insider Trades

  • RA CAPITAL MANAGEMENT, L.P. bought 6.39K (~$159.04K) on May 12, 2026.
  • RA CAPITAL MANAGEMENT, L.P. bought 14.15K (~$346.23K) on May 11, 2026.
  • RA CAPITAL MANAGEMENT, L.P. bought 25.72K (~$643.00K) on May 11, 2026.

Common questions about COAG

What do analysts rate COAG?
The average price target is $0.00.
Does Rallies show COAG price targets?
Yes. Rallies tracks COAG analyst ratings, consensus rating, average price target, upgrades, downgrades, analyst firms, and recent price target changes when available.
Is COAG research on Rallies investment advice?
No. Rallies provides research, data, and educational context for COAG. It does not provide personalized investment advice.
COAG

COAG